Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Andersen

Showing results (131-140 of 241) with videos related to

Pageof 25
Sort By:
American Journal of Human Genetics|February 29, 2008
Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intoleranceFanny Mochel, Melanie A Knight, Wing-Hang Tong, et al.
European Journal of Human Genetics : EJHG|January 26, 2012
Homozygous SMN2 deletion is a protective factor in the Swedish ALS populationPhilippe Corcia, Caroline Ingre, Helene Blasco, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2009
Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosisFrancois Gros-Louis, Peter M Andersen, Nicolas Dupre, et al.
Lakartidningen|October 4, 2008
[Representantives of the Swedish Neurological Association: Swedish neurology needs strong resource reinforcement]Anja Smits, Peter M Andersen, Magnus Andersson, et al.
Neurobiology of Aging|December 21, 2019
SQSTM1/p62 variants in 486 patients with familial ALS from Germany and SwedenRüstem Yilmaz, Kathrin Müller, David Brenner, et al.
Chemico-Biological Interactions|December 28, 2016
Instability of C154Y variant of aldo-keto reductase 1C3Satoshi Endo, Sayaka Takada, Ryo P Honda, et al.
Stem Cell Research|June 22, 2018
NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneuronsJulia Higelin, Alberto Catanese, Lena Luisa Semelink-Sedlacek, et al.
Plos One|November 19, 2010
Angiogenin levels and ANG genotypes: dysregulation in amyotrophic lateral sclerosisRussell Lewis McLaughlin, Julie Phukan, William McCormack, et al.
Annals of Neurology|November 4, 2015
Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosisPatrick Weydt, Patrick Oeckl, André Huss, et al.
Brain : a Journal of Neurology|January 12, 2022
The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosisKristiana Salmon, Matthew C Kiernan, Seung H Kim, et al.
Pageof 25

Showing results (131-140 of 241) with videos related to

Sort By:
Pageof 25
American Journal of Human Genetics|February 29, 2008
Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intoleranceFanny Mochel, Melanie A Knight, Wing-Hang Tong, et al.
European Journal of Human Genetics : EJHG|January 26, 2012
Homozygous SMN2 deletion is a protective factor in the Swedish ALS populationPhilippe Corcia, Caroline Ingre, Helene Blasco, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2009
Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosisFrancois Gros-Louis, Peter M Andersen, Nicolas Dupre, et al.
Lakartidningen|October 4, 2008
[Representantives of the Swedish Neurological Association: Swedish neurology needs strong resource reinforcement]Anja Smits, Peter M Andersen, Magnus Andersson, et al.
Neurobiology of Aging|December 21, 2019
SQSTM1/p62 variants in 486 patients with familial ALS from Germany and SwedenRüstem Yilmaz, Kathrin Müller, David Brenner, et al.
Chemico-Biological Interactions|December 28, 2016
Instability of C154Y variant of aldo-keto reductase 1C3Satoshi Endo, Sayaka Takada, Ryo P Honda, et al.
Stem Cell Research|June 22, 2018
NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneuronsJulia Higelin, Alberto Catanese, Lena Luisa Semelink-Sedlacek, et al.
Plos One|November 19, 2010
Angiogenin levels and ANG genotypes: dysregulation in amyotrophic lateral sclerosisRussell Lewis McLaughlin, Julie Phukan, William McCormack, et al.
Annals of Neurology|November 4, 2015
Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosisPatrick Weydt, Patrick Oeckl, André Huss, et al.
Brain : a Journal of Neurology|January 12, 2022
The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosisKristiana Salmon, Matthew C Kiernan, Seung H Kim, et al.
Pageof 25